Cited by 7Retinal Diseases and TreatmentsAngiogenesis and VEGF in CancerOcular Diseases and Behçet’s Syndrome

The Role of the Mitogen-Activated Protein Kinase Pathway in the Development of Laser-Induced Choroidal Neovascularization

Open access
Jang, Sun Young, Yang, Jin Young, Park, Jin Hwan, Kim, Yeji, An, Sumin, Jung, Wook Hyun, Park, Jong-Whi, Han, Jung Woo +4 more·2025·International Journal of Molecular Sciences

Abstract

The role of the mitogen-activated protein kinase (MAPK) pathway in choroidal neovascularization (CNV) remains unclear. This study investigates the involvement of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 pathways in CNV development, as well as the therapeutic potential of sprouty 2 (SPRY2), an MAPK inhibitor, in a laser-induced mouse model. The expressions of ERK, JNK, and p38 proteins were analyzed using Western blotting and immunostaining. Immunofluorescence imaging revealed increased p-ERK and p-JNK expression in the retina, retinal pigment epithelium (RPE), and choroid up to day 7. Co-immunostaining showed p-ERK colocalized with CD31, CD11b, F4/80, cytokeratin, and GFAP in the retina, while p-JNK and p-p38 were associated with angiogenesis and inflammation throughout the retina and choroid. Compared to aflibercept, SPRY2 administration significantly inhibited CNV lesions, endothelial proliferation, fibrosis, and apoptosis, while better-preserving RPE integrity. SPRY2-treated mice showed a stronger reduction in CNV-related inflammation, epithelial-mesenchymal transition, and photoreceptor apoptosis. These results highlight the MAPK pathway's role in CNV pathogenesis, with ERK primarily mediating Müller cell gliosis and JNK, contributing to angiogenesis and inflammation. SPRY2 effectively suppressed CNV lesions, supporting its potential as a therapeutic target for CNV treatment via MAPK pathway modulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms26062585

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 45 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Jang, S. Y., Yang, J. Y., Park, J. H., Kim, Y., An, S., Jung, W. H., Park, J.-W., Han, J. W., Kim, J. H., Park, H. S., Lyu, J., & Park, T. K.
Affiliations
  • Soonchunhyang University Hospital Bucheon (KR)
  • Gachon University (KR)
  • Konyang University (KR)
Corresponding author
  • Lyu, Jungmook
  • Park, Tae Kwann
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2025-03-13
Volume
26
Issue
6
Pages
2585
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4408412391
Cited by
7
References
45
Citations by year
2026: 5 · 2025: 2
FWCI
5.91
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Research Council of Science and Technology (GTL24021-201, RS-2022-KH125938)
  • Ministry of Health and Welfare (GTL24021-201, RS-2022-KH125938)
  • Soonchunhyang University (GTL24021-201, RS-2022-KH125938)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
choroidal neovascularization, MAPK signaling, ERK, JNK, p38 MAPK, Sprouty2, MAPK inhibitors, laser-induced CNV, retinal pigment epithelium, Müller cell gliosis, choroidal angiogenesis, inflammation, epithelial-mesenchymal transition, photoreceptor apoptosis, aflibercept
MeSH terms
Animals, Choroid, Disease Models, Animal, Lasers, Male, Membrane Proteins, Mice, Inbred C57BL, Recombinant Fusion Proteins, Retina, Apoptosis, Choroidal Neovascularization, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, Vascular Endothelial Growth Factor, Intracellular Signaling Peptides and Proteins, Mice, Retinal Pigment Epithelium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review